{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/adverse-drug-reactions/how-this-topic-was-developed/declarations-of-interest/","result":{"pageContext":{"chapter":{"id":"1a62db49-0d92-514d-9a4a-dfa05227ec25","slug":"declarations-of-interest","fullItemName":"Declarations of interest","depth":2,"htmlHeader":"<!-- begin field 23975c5b-a877-4b44-85ae-a7f30015be8f --><h2>Declarations of interest</h2><!-- end field 23975c5b-a877-4b44-85ae-a7f30015be8f -->","summary":null,"htmlStringContent":"<!-- begin item 16b3228b-68fe-4cc6-baf9-a7f30015bd73 --><!-- begin field d1736fe5-ace1-4185-bb62-a7f30015be8f --><h2>Our policy</h2><!-- end field d1736fe5-ace1-4185-bb62-a7f30015be8f --><!-- begin field 4e1d8a47-5739-41dc-a7b9-a7f30015be8f --><p>Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the <a href=\"https://cks.clarity.co.uk/\" data-hyperlink-id=\"3fcd2e30-e5ea-4fdf-a5eb-a992002b2fc8\">Clarity Informatics website</a>. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:</p><ul><li>Personal financial interests</li><li>Personal family interest</li><li>Personal non-financial interest</li><li>Non-personal financial gain or benefit</li></ul><p>Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.</p><!-- end field 4e1d8a47-5739-41dc-a7b9-a7f30015be8f --><!-- begin field c969de91-2fb0-4ac9-b38d-a7f30015be8f --><h2>Who should declare competing interests?</h2><!-- end field c969de91-2fb0-4ac9-b38d-a7f30015be8f --><!-- begin field a567a03b-10d2-4e71-86aa-a7f30015be8f --><p>Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.</p><!-- end field a567a03b-10d2-4e71-86aa-a7f30015be8f --><!-- begin field 1be9cda0-927e-48bd-ad64-a7f30015be8f --><h2>Competing interests declared for this topic:</h2><!-- end field 1be9cda0-927e-48bd-ad64-a7f30015be8f --><!-- begin field 67708a16-a84f-4723-be58-a7f30015be8f --><p>None.</p><!-- end field 67708a16-a84f-4723-be58-a7f30015be8f --><!-- end item 16b3228b-68fe-4cc6-baf9-a7f30015bd73 -->","topic":{"id":"5891f47f-d14e-5ade-b43e-09ab2ee894c3","topicId":"fb7af4be-ae9d-4213-b2ca-ca17ddb868c1","topicName":"Adverse drug reactions","slug":"adverse-drug-reactions","lastRevised":"Last revised in March 2017","chapters":[{"id":"78737b02-a5d5-5686-924f-3bd67a984373","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3124c32f-664e-57ef-805a-95067102ad32","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"23e3d730-4bbb-5a3a-bd97-77a17bee3f53","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0974ec45-5b01-515b-b02e-5cad23aacea1","slug":"changes","fullItemName":"Changes"},{"id":"6474141f-1642-5857-9d25-033f3b7503f0","slug":"update","fullItemName":"Update"}]},{"id":"5bad1097-961b-5653-8f9b-6456f05b7836","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6be883ff-72cf-54e9-b064-31f4df584e67","slug":"goals","fullItemName":"Goals"},{"id":"c6cc81cc-134f-5d98-b79c-967bf65bddd3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"95dab13c-419c-5de3-b7fd-95118f8b48e5","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d675aba3-9d84-5b1a-9c2b-79cc7bcab6c3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cd63cb73-82b3-5c83-bea6-b82fa98f7888","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"977ca222-407c-5643-a723-eeee2b2f6c0f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b68bacaa-d4b5-58a7-b9d6-46bf7c82f8ad","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"26252f90-7908-554e-8535-a49168c8bf4a","slug":"definition","fullItemName":"Definition"},{"id":"68cfd9ca-f6d9-582b-a898-39bd0927455f","slug":"categorization-of-adrs","fullItemName":"Categorization of ADRs"},{"id":"2bf3267e-f0ed-5301-b659-3a0d290262bc","slug":"health-financial-implications-of-adrs","fullItemName":"Health and financial implications of ADRs"},{"id":"804b9155-4dc6-574d-b5b3-3e320dd07967","slug":"monitoring-adverse-drug-reactions","fullItemName":"Monitoring adverse drug reactions"}]},{"id":"753ee7eb-1c21-5cf5-8e2e-e0e3ebd8be4a","fullItemName":"Management","slug":"management","subChapters":[{"id":"1d7dbb3f-b730-5e84-aea1-49ed9234a126","slug":"adverse-drug-reactions","fullItemName":"Scenario: Adverse drug reactions"}]},{"id":"95500d82-4a44-5f81-befc-15cfb88abd53","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"77a8b838-04cb-5545-affe-c92faa19e1bb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"dfa6f9b0-4f82-5b25-99fb-5ce802d731e8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f85a17d1-c7b8-5ebf-a80c-88c2f6c69eff","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5aee896a-ac4b-5a54-bde2-0577412d6418","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8054ea0e-276d-5167-818e-fec1d38114aa","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1a62db49-0d92-514d-9a4a-dfa05227ec25","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86d8d508-d776-5c0a-be24-6df70fb79006","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"77a8b838-04cb-5545-affe-c92faa19e1bb","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}